1+ day, 3+ hour ago   (502+ words) Guest Column | August 25, 2026 By Varun Venkatachalam and Jim Morris, IQS Consulting This article explores the following: From our perspective, implementation should be treated as a quality design activity, not a technical deployment. The objective is not to switch the system…...

1+ day, 17+ hour ago   (151+ words) Bioprocess Online Systemic Modularity: A Roadmap To Flexible, Efficient Biopharmaceutical Manufacturing Siemens in cooperation with Cytiva and Brooks Instruments Modern biopharmaceutical manufacturing is shifting away from rigid, single-product facilities toward flexible, adaptable operational models. Overcoming the limitations of purpose-built equipment…...

2+ day, 17+ hour ago   (181+ words) Bioprocess Online A Unified Development Blueprint For Accelerating Timelines: DNA To DS Bulk Fill In 8.5 months When a molecule falls outside conventional parameters, the efficiencies that standardized platforms promise often erode downstream, surfacing as late-stage rework, extended analytical timelines, or…...

6+ day, 22+ hour ago   (141+ words) Bioprocess Online Pushing The Boundaries Of Chromatographic Separation With Inert HPLC Column Hardware Metal-sensitive biomolecules can be difficult to measure reliably when unwanted interactions occur inside the LC flow path. Phosphorylated peptides, nucleotides, acidic metabolites, and other challenging analytes may…...

1+ week, 5+ hour ago   (1109+ words) Guest Column | August 19, 2026 A conversation between Elizabeth White of the Orphan Therapeutics Accelerator and Life Science Connect's Jon O'Connell No advanced therapy developer feels good about abandoning a clinical-phase orphan drug candidate that they know has a real chance at…...

1+ week, 4+ day ago   (141+ words) Bioprocess Online New Basal Medium To Support HPL-Supplemented Expansion Of MSCs Using PRIME-XV MSC Basal XSFM Scaling MSC manufacturing for clinical use depends on more than choosing the right supplement. The basal medium itself shapes expansion efficiency, and conventional options…...

2+ week, 3+ day ago   (151+ words) Bioprocess Online Separation Of A GLP-1 Receptor Agonist And Structurally Similar Impurities Using BioResolve™ Peptide Phenyl‑Hexyl+ And C18+ Columns By Hua Yang and Steve Shiner GLP-1 therapeutics are reshaping the biopharmaceutical market, but their peptide-based structures bring complex analytical challenges…...

2+ week, 5+ day ago   (1072+ words) Guest Column | August 6, 2026 By Jason Herche, VP, Digital Validation Solutions, Pinnaql In bioprocessing, we are comfortable talking about critical process parameters, yield, contamination control, and batch variability. We are less likely to talk about data in the same practical way,…...

2+ week, 6+ day ago   (138+ words) Beyond Flexibility: The Strategic Value Of Single-Use In Virus Filtration Bioprocess Online Beyond Flexibility: The Strategic Value Of Single-Use In Virus Filtration Ensuring viral safety is a crucial requirement in downstream bioprocessing, but traditional fixed-capacity stainless-steel infrastructure often creates significant…...

2+ week, 6+ day ago   (454+ words) Guest Column | August 5, 2026 By Sanjeev Luther, CEO, Ernexa Therapeutics The cell and gene therapy industry has advanced in its understanding of biology. Researchers now design therapies that not only target the disease directly but also reshape the immune system, modify…...